FineTech Pharmaceutical Ltd. focuses on development and production of low volume, high value specialty Active Pharmaceutical Ingredients.
We develop “by-passes” to process and polymorph patents by developing non-infringing processes or polymorphs which can be patented in their own right.
We offer a full range of services from paper chemistry to laboratory scale development to pilot scale and commercial production. In support of these services, we also offer analytical method development, regulatory affairs, and complete literature and patent analysis.
We are staffed with a team of highly qualified scientists who have vast experience in synthetic and analytical chemistry with expertise in multi-step synthesis, new polymorphs development, chiral and prostaglandin chemistry.
We operate on a 6 building campus, equipped with state-of-the-art laboratory, production and quality control equipment. Our FDA registered facility has the equipment versatility and unique operational capability to serve a wide variety of challenging requirements including working with controlled substances.
Since 2011, FineTech Pharmaceutical LTD. operates as a wholly-owned subsidiary of OPKO Health, a diverse healthcare group serving unmet needs with first-class products, comprehensive diagnostics laboratories, robust research and development pipeline and unique pharmaceutical business solutions.
